test

Phillip Fitzsimmons

@Hennion & Walsh Asset Management, Inc.

Latest period2024 - Q4ReportedManaged Assets$2.209BTotal holdings851
Assets growth rate3.15%Assets growth rate (2-Q avg)6.59%Continuous growth in asset value5 quarters

Portfolio positions

This chart displays the top 10 holdings in Hennion & Walsh Asset Management, Inc.'s 2024 - Q4 portfolio, based on their 13F SEC filing, out of a total of 851 positions.

Assets under management

The assets under management (AUM) of Hennion & Walsh Asset Management, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q4, they manage 2.209B in assets, with a quarterly growth rate of 3.15% and a 2-quarter average growth rate of 6.59%. The portfolio is managed by Phillip Fitzsimmons, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CORTCorcept Therapeutics Inc
Recent Activity
Decreased -30.58%
0.11%
$2.425M
48,122 shares@ $50.4 avg price
ENXEaton Vance New York Mun Bd
Recent Activity
Decreased -23.71%
0.11%
$2.338M
245,340 shares@ $9.53 avg price
DTMDt Midstream Inc
Recent Activity
Decreased -0.77%
0.11%
$2.313M
23,263 shares@ $99.43 avg price
RTXRtx Corporation
Recent Activity
Decreased -19.81%
0.11%
$2.293M
19,812 shares@ $115.72 avg price
SLBSchlumberger Ltd
Recent Activity
Decreased -13.39%
0.11%
$2.251M
58,708 shares@ $38.35 avg price
RNAAvidity Biosciences Inc
Recent Activity
Decreased -1.82%
0.11%
$2.234M
76,810 shares@ $29.09 avg price
BGHBarings Global Short Duratio
Recent Activity
Decreased -35.43%
0.11%
$2.21M
143,165 shares@ $15.45 avg price
ICSHIshares Tr
Recent Activity
Decreased -0.04%
0.1%
$2.182M
43,270 shares@ $50.43 avg price
CGCarlyle Group Inc
Recent Activity
Decreased -9.61%
0.1%
$2.169M
42,956 shares@ $50.5 avg price
KRYSKrystal Biotech Inc
Recent Activity
Decreased -1.66%
0.1%
$2.143M
13,678 shares@ $156.66 avg price